Search Results for "Brian Groves Pfizer Bio"

15:47 EST 28th February 2015 | BioPortfolio

Matching Channels

Pfizer

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have ...

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

Matching News

Remembering Brian Murphy

The MassBio team mourns the death of Brian P. Murphy, Cambridge's assistant city manager for community development. Brian has been a strong partner and advocate for responsible, sustainable growth of ...

Pfizer’s Investment Strategy

Pfizer recognises the importance of biotechnology and the need for good science. Barbara Dalton and Daniel Grant explain their different roles in Pfizer and the ways in which the company can invest to...

Pfizer Buying Hospira for $15.23B

NEW YORK (AP) — Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its established global pharmaceutical business.The buyout will also help Pfizer tap into the g...

Pfizer’s Out-licensing Opportunities

In 2008 Pfizer refined their R&D strategy and decided to decrease the number of therapeutic areas that their teams were focusing on. The result of this decision is that the company now has approximate...

My brain made me do it, but does that matter?

Imagine that Brian promises to drive you to the airport but never shows up, and you miss your flight. When you confront Brian, he tells you that he remembered his promise but decided to watch a movie ...

Pfizer: Biosimilars - A Significant Component of Driving Growth For Pfizer

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Diem Nguyen, General Manager of BioSimilars at Pfizer

Pfizer: An Ideal Development Partner

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Doug Giordano, Vice President, Business Development at Pfizer. Filmed at BIO-Europe 2009, they discuss: • the strategy behind...

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Investor Conference

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and CEO, at the BIO CEO and Investor Conference on Tuesday, Feb...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement